Third Time's the Charm for Encysive?
Motley Fool - 12 hours ago
Two weeks ago, it was the US Food and Drug Administration rejecting Encysive's approvable letter response because of an incorrectly formatted data table.
Encysive shares continue plunge BusinessWeek
Encysive Drops on FDA Delay TheStreet.com
FDA to review Encysive's drug application Houston Business Journal
Houston Chronicle - BusinessWeek
all 21 news articles